HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 11, November 2017 – Paediatric Illnesses       » Breakthrough new rice variety announced in Northern China       » Ebola vaccine approved in China       » Study reveals anti-cancer properties of a fungus used in traditional medicine       » Chinese scientists create genetically modified low-fat pigs       » China, Brazil and Russia are riskiest markets for compliance and regulation       » Why are Korean eggs salmonella-free?      
Events
The Antibody-based Bio-therapeutics Asian Forum 2016 (13-15 July 2016, Shanghai)
Forum Name: The Antibody-based Bio-therapeutics Asian Forum 2016
Event Date: July 13-15. 2016
Event Venue: Shanghai, PR. China
Event Website: www.abbforum.com
Event Contact: Wei Zhang, Program Manager
Telephone: ++86.21.6034.0229
Email: wzhang@deliver-consulting.com

The Antibody and Antibody-based Therapeutics, classified as the most significant portion of biologics, have entered the center stage of drug discovery and been increasingly reflected through the major shift of focus in pipeline by pharmaceutical companies from small molecules to a broader portfolio with both biologics and chemical agents. Roughly, as of Nov.10. 2014, 47 monoclonal antibody products have been approved in US or Europe and biologics have also been proven to have significant clinical advantages in the treatment of life-threatening diseases. Not only in Western countries, there have been also considerable biologics R&D, manufacturing and commercial activities in Asia. And in China, the Bio-industry has been designated as one of the seven strategic industries by the central government. Not so far away on Feb.28.2015, the China FDA has also released the country's first biosimilar guidelines to establish the basic principles for development and technical evaluation of bio-similars, towards the adoption of a more concrete and well-defined regulatory pathway to further promote the bio-industry. Upon these, through collaborating with SAPA-GP, supported by BioTaiwan, the Antibody-based Bio-therapeutics Asian Forum aims to provide a premier communication platform with scientific sessions on R&D, Regulatory and Bioprocess Strategies, contributing the 'Accessibility' and 'Affordability' of those life-saving therapies in the region.

2016 Key Discussions

  • Challenges, Opportunities and Future Trends in the R&D of Therapeutic Antibody
  • Key Considerations to Develop a World-class Therapeutic Antibody Industry in China
  • Similar, Bio-better and Novel Therapeutic Antibody Development Strategies
  • Innovative Platform and Technology for Antibody Generation and Engineering
  • ADC, Bi/Multi-specific and Next Generation Modalities of Antibody Therapy
  • Biologics Processing and CMC Strategies
NEWS CRUNCH  
news MIT Technology Review announces 2018's 10 'Innovators Under 35 Asia'
news Novogen becomes Kazia Therapeutics
news Transforming healthcare through innovation: addressing unmet healthcare needs in Asia Pacific
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye – the Window to your Soul
September:
Infectious Diseases
October:
A change of heart — Cardiovascular diseases
November:
Paediatric Illnesses
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy